Riley Antony A 4

4 · Forte Biosciences, Inc. · Filed Jan 13, 2026

Form 4

Period: 2026-01-12

CHIEF FINANCIAL OFFICER

Transactions

Award
Stock Option (right to buy)
[F1]
2026-01-12+90,000→ 90,000 total
Exercise: $29.66Exp: 2036-01-12→ Common Stock (90,000 underlying)
Award
Restricted Stock Units
[F2][F3]
2026-01-12+60,000→ 60,000 total
→ Common Stock (60,000 underlying)

Footnotes (3)

[F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month following the Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean January 1, 2026.
[F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Forte Biosciences, Inc. (the "Issuer") Common Stock.
[F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one fourth (1/4th) of the total RSUs subject to the award shall vest annually on the anniversary of Vesting Commencement Date such that all shares shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean January 1, 2026.

Signature

/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact|2026-01-13

Documents

1 file